Search

Your search keyword '"Mercier, Francois"' showing total 426 results

Search Constraints

Start Over You searched for: Author "Mercier, Francois" Remove constraint Author: "Mercier, Francois"
426 results on '"Mercier, Francois"'

Search Results

1. A Bayesian joint model of multiple nonlinear longitudinal and competing risks outcomes for dynamic prediction in multiple myeloma: joint estimation and corrected two-stage approaches

3. Duration of and time to response in oncology clinical trials from the perspective of the estimand framework

4. Association of Higher Ocrelizumab Exposure With Reduced Disability Progression in Multiple Sclerosis

6. Discovering material information using hierarchical Reformer model on financial regulatory filings

7. Hydrodynamic effects on biofilms at the bio-interface using a microfluidic electrochemical cell: case study of Pseudomonas sp

8. Microfluidic bioanalytical flow cells for biofilm studies: A review

9. Efficient transfer learning for NLP with ELECTRA

12. Ocrelizumab in relapsing and primary progressive multiple sclerosis: Pharmacokinetic and pharmacodynamic analyses of OPERA I, OPERA II and ORATORIO

13. CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax

16. Imaging dynamic mTORC1 pathway activity in vivo reveals marked shifts that support time-specific inhibitor therapy in AML.

18. Leukemia aggressiveness is driven by chromatin remodeling and expression changes of core regulators

27. mRNA Translation Inhibition Targets Bioenergetic Homeostasis in AML Cells in Vitro and In Vivo and Synergizes with Cytarabine and Venetoclax

31. Effect of NaCl on Pseudomonas biofilm viscosity by continuous, non-intrusive microfluidic-based approach

34. Correction: Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

35. Supplementary Data from Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

36. Data from Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

38. Estimands in oncology early clinical development: Assessing the impact of intercurrent events on the dose-toxicity relationship.

39. Data from TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity

40. Supplementary Data from TACIMA-218: A Novel Pro-Oxidant Agent Exhibiting Selective Antitumoral Activity

41. Supplementary Data TS1 from Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

42. Jesuit Relations and Allied Documents, vol. 51

43. Jesuit Relations and Allied Documents, vol. 53

44. Jesuit Relations and Allied Documents, vol. 40

45. Jesuit Relations and Allied Documents, vol. 52

46. Jesuit Relations and Allied Documents, vol. 41

47. Jesuit Relations and Allied Documents, vol. 50

50. Tumor Dynamic Model-Based Decision Support for Phase Ib/II Combination Studies: A Retrospective Assessment Based on Resampling of the Phase III Study IMpower150

Catalog

Books, media, physical & digital resources